^
BIOMARKER:

EGFR negative

i
Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Entrez ID:
EGFR negative
NSCLC
pembrolizumab + atezolizumab
Sensitive: B - Late Trials
EGFR negative
NSCLC
pembrolizumab
Sensitive: B - Late Trials
EGFR negative
NSCLC
anlotinib
Sensitive: C2 – Inclusion Criteria
EGFR negative
NSCLC
afatinib
Sensitive: C3 – Early Trials
EGFR negative
NSCLC
anlotinib + sintilimab
Sensitive: C3 – Early Trials
EGFR negative
NSCLC
sintilimab
Sensitive: C3 – Early Trials